Preserved plant genetic resources (hereafter referred to as „materials“) are made available by the Africa Rice Center (WARDA) under the following conditions: C. When it comes to for-profit industries or institutions, the typical MTA is not enough; Commercial rights are generally sought after, which often indicates that they operate on the basis of a standard commercial development and licensing contract. For simple transfers without intellectual property, the NIH recommends a simple matching agreement. For materials that can be patented or for which increased protection is desired, the Uniform Biological Material Transfer Agreement (UBMTA) can be used. Many U.S. educational institutions have signed the UBMTA Masteragrement.  AUTM (formerly the Association of University Technology Managers) serves as a repository for UBMTA`s original master`s contracts and keeps the list of signatories.  UBMTA signatories must only sign a letter of execution containing the details of each transfer, since they have already agreed to all the terms of the master contract. An MTA should allow the recipient of the materials to publish or present the recipient`s search results without the supplier`s consent. An MTA may require the recipient to send the Supplier, prior to publication or presentation, a copy of a manuscript, summary, poster session or presentation, so that the Supplier can verify, comment or request the removal of confidential information from the Supplier.
An audit period of 30 to 45 days is sufficient for most providers and is acceptable to most university recipients. The MTA may require that publication or submission be delayed for a longer period of time in order to allow patent applications to be filed. For most suppliers, an additional 30 to 45 days is sufficient. An MTA may also require the recipient to confirm the supplier for the availability of material in publications or presentations. An in-depth MTA protects a researcher`s ability to exploit and publish research, existing and potential intellectual property, and define the use of associated confidential information. The revision of a thorough MTA ensures that the terms of the contract are not in contradiction with the rights granted in other research agreements. The definition of materials should be limited to the definition of materials actually transferred, including unchanged descendants and derivatives, and should not include substances or inventions produced by the recipient of the materials. The descendants, as defined in the Uniform Biological Material Material Agreement (UBMTA), are unchanged descendants of the original material. Descendants may include a virus from a virus, a cell cell or an organism.
The unchanged derivatives are, according to the UBMTA, substances produced by the recipient, which constitute an unchanged functional sub-unit or a product of expression of the material initially supplied. Unchanged derivatives may include purified or split subsets of the original material; descendants or derivatives; sub-clone of unchanged cell lines; transcription and translation products such as RNA and proteins from the DNA provided; Reverse translation and reverse translation products, such as DNA. B, are synthesized on a model with the RNA provided; monoclonal antibodies that are secreted by a line of hybrid cells; and chemically synthesized copies.